3Dershwitz M,Randel GI,Rosow CE,et al.Initial clinical experience with remifentanil,a new opioid metabolized by esterases.Anesth Analg,1995,81:619-623.
4Vuyk J.Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions.Acta Anaesthesiol Belg,2001,52:445-451.
5Glass PS,Gan TJ,Howell S.A review of the pharmacokinetics and pharmacodynamics of remifentanil.Anesth Analg,1999,89:S7-14.
6Olivier P,Sirieix D,Dassier P,et al.Continuous infusion of remifentanil and target-controlled infusion of propofol for patients undergoing cardiac surgery:a new approach for scheduled early extubation.J Cardiothorac Vasc Anesth,2000,14:29-35.
7Guarracino F,Penzo D,De Cosmo D,et al.Pharmacokineticbased total intravenous anaesthesia using remifentanil and propofol for surgical myocardial revascularization.Eur J Anaesthesiol,2003,20:385-390.
8Drover DR,Lemmens HJ.Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery.Anesthesiology,1998,89:869-877.
9Wietasck G,Scholz M,Zinserling J,et al.Propofol clearance is decreased by remifentanil.Anesthesiology,1999,91:A443.
10Ropcke H,Konen-Bergmann M,Cuhls M,et al.Propofol and remifentanil pharmacodynamic interaction during orthopedic sur gical procedures as measured by effects on bispectral index.J Clin Anesth,2001,13:198-207.
3Brueckner S, Reinke U, Roth-Isigkeit A, et al. Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty [ J ]. J Clin Anesth, 2003, 15(6) :433 -440.
4Siegel R,Naishadham D,Jemal A.Cancer statistics,2012.CA Cancer J Clin,2012,62:10-29.
5Kang WS,Kim SY,Son JC,et al.The effect of dexmedetomidine on the adjuvant propofol requirement and intraoperative hemodynamics during remifentanil-based anesthesia.Korean J Anesthesiol,2012,62:113-118.
